Oncology Institute (TOI) Retained Earnings (2020 - 2025)
Oncology Institute's Retained Earnings history spans 6 years, with the latest figure at -$271.4 million for Q4 2025.
- For Q4 2025, Retained Earnings fell 28.75% year-over-year to -$271.4 million; the TTM value through Dec 2025 reached -$271.4 million, down 28.75%, while the annual FY2025 figure was -$271.4 million, 28.75% down from the prior year.
- Retained Earnings reached -$271.4 million in Q4 2025 per TOI's latest filing, down from -$263.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$18.4 million in Q1 2021 to a low of -$271.4 million in Q4 2025.
- Average Retained Earnings over 5 years is -$129.3 million, with a median of -$118.7 million recorded in 2023.
- Peak YoY movement for Retained Earnings: increased 0.24% in 2022, then tumbled 144.64% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$63.2 million in 2021, then increased by 0.24% to -$63.1 million in 2022, then plummeted by 131.68% to -$146.2 million in 2023, then plummeted by 44.24% to -$210.8 million in 2024, then fell by 28.75% to -$271.4 million in 2025.
- Per Business Quant, the three most recent readings for TOI's Retained Earnings are -$271.4 million (Q4 2025), -$263.9 million (Q3 2025), and -$247.4 million (Q2 2025).